High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

Published:2011-09 Issue:9 Volume:106 Page:1638-1645
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Eaton John E,Silveira Marina G,Pardi Darrell S,Sinakos Emmanouil,Kowdley Kris V,Luketic Velimir A C,Harrison Edwyn M,McCashland Timothy,Befeler Alex S,Harnois Denise,Jorgensen Roberta,Petz Jan,Lindor Keith D

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2011156.pdf

Reference38 articles.

1. Cancer risk in patients with inflammatory bowel disease.;Lewis;Gastroenterol Clin N Am,1999

2. Primary sclerosing cholangitis.;Silveira;Can J Gastroenterol,2008

3. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.;Marchesa;Am J Gastroenterol,1997

4. High-dose ursodeoxycholic acid for treatment of primary sclerosing cholangitis.;Lindor;Hepatology,2009

5. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis Ursodoexycholic Acid Study Group.;Lindor;N Engl J Med,1997

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Primary Sclerosing Cholangitis Including Transplantation;Clinics in Liver Disease;2024-02

2. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data;International Journal of Molecular Sciences;2024-01-11

3. Cholesterol in colorectal cancer: an essential but tumorigenic precursor?;Frontiers in Oncology;2023-11-03

4. The Potential of Bile Acids as Biomarkers for Metabolic Disorders;International Journal of Molecular Sciences;2023-07-28

5. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease;World Journal of Gastroenterology;2023-07-21